Ustekinumab Trough Concentrations Associated with Biochemical Outcomes in Patients with Crohn's Disease
JOURNAL OF CROHNS & COLITIS(2022)
Abstract
In this real-world cohort of patients with CD, UST levels in the highest quartile (≥ 6.3 µg/mL) at week 8 were associated with higher biochemical remission rates at week 24.
MoreTranslated text
Key words
Crohn’s disease,Inflammatory bowel disease,Pharmacokinetics,Ustekinumab
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined